Netherlands · 
What does Forbion Capital Partners invest in?
Forbion Capital Partners invests most often at Series A and Series B (68% of the rounds on record), in sectors such as Ehealth, Connected Health and Health.
Forbion Capital Partners highlights
- 01
23 cheques in the last 12 months
- 02
Mostly Series A and Series B: 68% of its rounds
- 03
Sole investor in 10 rounds, median $17M
- 04
8 exits from the portfolio
What they do
Forbion is a global venture capital firm dedicated to advancing groundbreaking biotech innovations and other sustainable solutions.From their own website
- Type
- Private equity (from a list, unverified)
- Cheque size
- $100K – $5.0M as they say
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- EhealthConnected HealthHealth
- Based in
- Naarden, Netherlands
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first134 appearances
- 2026
16 rounds
- Oct
- Sept
- Sept
- Sept
- Sept
- Jul
- Jun
- Jun
- Jun
- May
- Mar
- Mar
- Feb
- Feb
- Jan
- Jan
- 2025
22 rounds
- Dec
- Dec
- Dec
- Dec
- Nov
- Nov
- Nov
- Oct
- Oct
- Oct
- Sept
- Sept
- Jul
- Jun
- May
- May
- Apr
- Apr
- Apr
- Feb
- Jan
- Jan
- 2024
18 rounds
- Dec
- Dec
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration2 named
MAMartien Adrianus Van OschManaging MemberiForm ADV
VVVincent Van HoutenChief Financial OfficeriForm ADV
We also hold 30 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$6.9Bgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- FCPM III Services B.v.
- SEC number
- CRD 162925
Who backs their funds
1 LP on record in Forbion Capital Partners's funds
- Committed
- $853M
- Funds
- 4
- Vintages
- 2023 to 2024
The institutions that put money into its funds, which the firm then invests in companies.Source: the pension's own report, latest Mar 2026.
California Public Employees' Retirement System (CalPERS)4 funds$853M
Fund Vintage Committed Forbion Growth Opportunities Fund III Co?peratief U.A. 2024 $384M Forbion Ventures Fund VII Co?peratief U.A. 2024 $272M Forbion Ventures Fund VI Cooperatief U.A. 2023 $180M Forbion Growth Opportunities Fund II Cooperatief U.A. 2023 $17M
What they claim to have backed
From their own portfolio page (on their website)
0 of 1 we have independently watched raise
Made with Friend Studio
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
Exits from the portfolio
Companies it backed that were later bought or listed8 in all
Dezima PharmaBought by Amgen$300MSept 2015
Santaris PharmaBought by Roche$450MAug 2014
CircuLiteBought by HeartWare International$30MDec 2013
bluebird bioListed$101MJun 2013
Pathway Medical TechnologiesBought by MEDRADUndisclosedSept 2011
Fovea PharmaceuticalsBought by Sanofi AventisUndisclosedOct 2009
An exit counts when it came after the firm's first round in the company. From historical deal records.